Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$757M |
| 2 |
Microsoft
MSFT
|
+$725M |
| 3 |
Apple
AAPL
|
+$628M |
| 4 |
Amazon
AMZN
|
+$487M |
| 5 |
Meta Platforms (Facebook)
META
|
+$355M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$121M |
| 2 |
KE Holdings
BEKE
|
+$31.8M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$24.4M |
| 4 |
X
US Steel
X
|
+$18.4M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
+$15.6M |
Sector Composition
| 1 | Technology | 34.97% |
| 2 | Consumer Discretionary | 11.79% |
| 3 | Communication Services | 10.31% |
| 4 | Healthcare | 9.95% |
| 5 | Industrials | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Buckle
BKE
$3.04B
| $2.68M | ﹤0.01% |
59,000
| – | – |
|
1627
Benchmark Electronics
BHE
$1.41B
| $2.68M | ﹤0.01% |
68,900
-900
| -1% | -$34.9K |
|
|
ELME
1628
Elme Communities
ELME
$1.51B
| $2.67M | ﹤0.01% |
168,100
-2,400
| -1% | -$38.2K |
|
1629
MasterBrand
MBC
$1.71B
| $2.67M | ﹤0.01% |
243,900
-2,300
| -0.9% | -$25.1K |
|
1630
Melco Resorts & Entertainment
MLCO
$3.75B
| $2.66M | ﹤0.01% |
368,147
| – | – |
|
1631
Stellar Bancorp
STEL
$1.61B
| $2.65M | ﹤0.01% |
94,862
-3,500
| -4% | -$97.9K |
|
1632
Blue Bird Corp
BLBD
$1.84B
| $2.65M | ﹤0.01% |
61,300
+1,900
| +3% | +$82K |
|
1633
Tennant Co
TNC
$1.5B
| $2.64M | ﹤0.01% |
34,100
-600
| -2% | -$46.5K |
|
|
NTST
1634
NETSTREIT Corp
NTST
$1.75B
| $2.64M | ﹤0.01% |
156,000
-2,100
| -1% | -$35.6K |
|
1635
Omnicell
OMCL
$1.46B
| $2.64M | ﹤0.01% |
89,800
| – | – |
|
1636
Amicus Therapeutics
FOLD
$2.46B
| $2.63M | ﹤0.01% |
458,700
+24,500
| +6% | +$140K |
|
1637
LendingClub
LC
$1.91B
| $2.62M | ﹤0.01% |
217,760
| – | – |
|
1638
Vital Farms
VITL
$2.17B
| $2.6M | ﹤0.01% |
67,600
+4,000
| +6% | +$154K |
|
1639
ACM Research
ACMR
$1.92B
| $2.6M | ﹤0.01% |
100,500
| – | – |
|
1640
Harmony Biosciences
HRMY
$1.86B
| $2.6M | ﹤0.01% |
82,200
-700
| -0.8% | -$22.1K |
|
|
NVEE
1641
DELISTED
NV5 Global
NVEE
| $2.59M | ﹤0.01% |
112,100
-1,400
| -1% | -$32.3K |
|
1642
Reynolds Consumer Products
REYN
$4.84B
| $2.58M | ﹤0.01% |
120,400
-1,800
| -1% | -$38.6K |
|
1643
Tarsus Pharmaceuticals
TARS
$2.08B
| $2.57M | ﹤0.01% |
63,533
+8,000
| +14% | +$324K |
|
1644
Turning Point Brands
TPB
$1.84B
| $2.57M | ﹤0.01% |
33,900
-400
| -1% | -$30.3K |
|
|
ARR
1645
Armour Residential REIT
ARR
$1.72B
| $2.57M | ﹤0.01% |
152,763
+44,700
| +41% | +$751K |
|
1646
Rush Street Interactive
RSI
$2.02B
| $2.56M | ﹤0.01% |
172,100
+9,000
| +6% | +$134K |
|
1647
AMC Entertainment Holdings
AMC
$1.44B
| $2.56M | ﹤0.01% |
825,291
+86,200
| +12% | +$267K |
|
1648
Schneider National
SNDR
$4.18B
| $2.56M | ﹤0.01% |
105,900
-1,300
| -1% | -$31.4K |
|
1649
Clarivate
CLVT
$2.88B
| $2.55M | ﹤0.01% |
592,300
-27,000
| -4% | -$116K |
|
1650
Rapid7
RPD
$1.27B
| $2.54M | ﹤0.01% |
110,000
-6,400
| -5% | -$148K |
|